NCT05704985 2025-05-29Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ TumorsDEKA BiosciencesPhase 1 Active not recruiting39 enrolled
NCT06026254 2024-11-18A Rollover Study for Subjects Who Completed Participation in IMSA101-101 TrialImmuneSensor Therapeutics Inc.Phase 1 Active not recruiting2 enrolled